Delay in administration of epinephrine is associated with decreased survival among children with in-hospital cardiac arrest with an initial non-shockable rhythm. Whether this association is applicable to paediatric out-of-hospital cardiac arrest (OHCA) population remains unknown. We aimed to determine whether time to epinephrine administration is associated with outcomes in paediatric OHCA. 
Introduction
More than 120 000 Japanese patients experience an out-of-hospital cardiac arrest (OHCA) every year, with paediatric patients accounting for approximately 1%. [1] [2] [3] [4] As few as 10% of paediatric OHCA patients survive with favourable neurological outcomes. 3, 4 Although evidence supporting interventions for adult OHCA is commonly extrapolated to paediatric OHCA due to scarce evidence in paediatric OHCA, poor survival rates persist. Administration of epinephrine for paediatric OHCA is one such example.
Current international cardiopulmonary resuscitation (CPR) guidelines recommend administration of epinephrine in paediatric cardiac arrest. 5, 6 Theoretically, epinephrine is thought to produce beneficial effects during CPR because the strong alpha-adrenergic effects of epinephrine can increase coronary perfusion through increased aortic diastolic pressure and help to maintain cerebral perfusion. 7, 8 However, there are no randomized clinical trials (RCTs) directly examining the effectiveness of epinephrine use during CPR in paediatric cardiac arrest. 9, 10 A very few clinical studies have examined the potential effect of epinephrine in paediatric cardiac arrest. 11, 12 Although several studies have examined the dose of epinephrine, 11, 13, 14 there had been no studies addressing the timing of administration of epinephrine until a recent study reported the association between delay in administration of epinephrine and poor outcomes in paediatric in-hospital cardiac arrest. 15 We hypothesized that delayed administration of epinephrine for paediatric OHCA would likewise be associated with poor outcomes.
Materials and methods
Study design, setting, and participants
We used the All-Japan Utstein Registry, the Fire and Disaster Management Agency (FDMA) sponsored, prospective nation-wide population-based database of OHCA in Japan. Details of the design of the All-Japan Utstein Registry and the Japanese emergency medical service (EMS) system have been described previously. [1] [2] [3] [4] [16] [17] [18] All OHCA patients, including those with prior do-not-resuscitate orders, are transported to an emergency hospital except in specific situations (e.g. decapitation, rigor mortis, livor mortis, and decomposition) because EMS personnel are not allowed to terminate resuscitation out-of-hospital in Japan. Data are collected from three sources (i.e. 1-1-9 dispatch centres, fire stations, and receiving hospitals) and are integrated into the All-Japan Utstein Registry system on the FDMA database server. The registry utilizes standardized Utstein-style templates for OHCA to facilitate uniform reporting by using precisely defined variables and outcomes. 19, 20 The integrity, accuracy, and completeness of the data are optimized through rigorous certification by the FDMA and the logical internal checks with standardized software.
The Japanese CPR guidelines largely conform to the American Heart Association CPR guidelines. Emergency lifesaving technicians (ELST) (highly trained EMS personnel) are permitted to secure intravenous lines under the instruction of medical directors in most municipalities. Epinephrine can be administered via intravenous line by specially trained ELST who have completed an additional 220 h of training and participated in 10 supervised administrations of epinephrine in training hospitals. Epinephrine administration by specially trained EMS personnel officially started in April 2006. However, most municipalities restrict administration of epinephrine to patients older than 8 years old.
This study cohort was based on data submitted to the All-Japan Utstein Registry from 1 January 2005 to 31 December 2012. We included paediatric patients aged <18 years, excluding neonates or infants aged <1 year, who received at least a single administration of epinephrine during out-of-hospital resuscitation. We excluded patients who received epinephrine before the emergency call or just after hospital arrival. Patients with missing data on prehospital epinephrine use accounted for less than 1% of all paediatric OHCA patients ( Figure 1) .
This study was conducted in accordance with the amended Declaration of Helsinki and was approved by the institutional review board of University of the Ryukyus with a waiver of informed consent due to the anonymous nature of the data. whereas timings of additional administrations were not recorded, although the number of epinephrine doses was recorded. Time to epinephrine was defined as the interval in minutes from emergency call to the first administration of epinephrine. A time to epinephrine of 1 min indicates that epinephrine was given within the next whole minute after the emergency call was received, because the recording of the time of the emergency call and the first administration of epinephrine was conducted in whole minutes.
Data collection
Aetiology of cardiac arrest determined by the attending physician in the emergency department was roughly classified as follows: cardiac cause, cerebrovascular disease, respiratory disease, malignant tumour, external cause, and others. Unless there was evidence suggesting a noncardiac cause, the aetiology was presumed to be cardiac cause. 20 Through a follow-up survey 30 days after OHCA, EMS personnel reconfirmed the aetiology of the cardiac arrest and collected data on survival and neurological status on the basis of an inquiry for the medical director.
The primary outcome was overall survival 30 days after OHCA. The secondary outcomes were prehospital return of spontaneous circulation (ROSC) and 30-day neurologically favourable survival. Neurological status was assessed by the inpatient attending physician using the GlasgowPittsburgh cerebral performance category (CPC) scores, in which a score of 1 indicates good performance; 2, moderate disability; 3, severe disability; 4, vegetative state; and 5, death. A CPC score of 1-2 was considered a favourable neurological status, and a CPC score of 3-5 was considered a poor neurological status, as defined in adult cardiac arrest studies. 20, 21 However, paediatric CPC (PCPC) scores are widely used to assess neurological outcome in children. 22, 23 Although no universal definition has been established for a favourable neurological outcome in paediatric cardiac arrest by using PCPC scores, many previous studies have regarded PCPC scores of 1-3 or 1-2 as a favourable neurological outcome. 15, [24] [25] [26] We regarded a CPC score of 1-2 as equivalent to a PCPC score of 1-3, defined as good performance to moderate disability. However, due to the difficulty in distinguishing patients with mild disability (equivalent to a PCPC score of 2) from the All-Japan Utstein registry data, we could not perform analysis using another frequently used definition of a favourable neurological outcome, defined as good performance to mild disability (equivalent to a PCPC score of 1-2). Instead, we did the analysis using a CPC score of 1 (equivalent to a PCPC score of 1) in addition to a CPC score of 1-2.
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Statistical analysis
The study cohort was characterized by using descriptive statistics. We presented categorical variables as counts with proportions and continuous variables as means with standard deviations (SDs) or medians with interquartile ranges (IQRs). The v 2 test was used to compare categorical variables and the t-test or the Wilcoxon Mann-Whitney test was used to compare continuous variables. To examine the association between time to epinephrine and 30-day survival, Cochran-Armitage trend test was used when time to epinephrine was treated as a categorical variable (categorized into < _10, 11-15, 16-20, 21-25, 26-30, or >30 min) and a univariable logistic regression model was used when time to epinephrine was treated as a linear and continuous variable. To assess the independent association between time to epinephrine and 30-day survival, we used a multivariable logistic regression model. For the primary analysis, we treated time to epinephrine as a linear and continuous variable. The following variables for which the imbalances were found between 30-day survivors and non-survivors on univariable analyses were included in the models: time from call to epinephrine, bystander witness (witnessed or unwitnessed), PAD (shock delivered or undelivered), first documented rhythm (shockable or non-shockable), and aetiology of cardiac arrest (cardiac or non-cardiac).
The results from the uni-and multi-variable logistic regression models were reported as crude and adjusted odds ratios (ORs) with their 95% confidence intervals (CIs).
To analyse secondary outcomes (prehospital ROSC or neurologically favourable survival), including different definitions of favourable neurological outcomes, similar multivariable regression models were used, and ORs and their 95% CIs were reported.
To further characterize the association between time to epinephrine and 30-day survival, we conducted a pre-planned analysis in which time to epinephrine was divided into two time intervals [time from call to contact with patient (response time) and time from contact with patient to epinephrine use (procedure time)] as a previous paediatric OHCA study indicated that shorter response time might be associated with increased chance of survival. 27 We also performed an analysis in which time to epinephrine was classified into two groups [early (<20 min) or late (> _20 min)] based on the value of the first quartile of time to epinephrine. The first quartile of time to epinephrine was 20 min, and more than 90% of patients received treatment by EMS personnel at that point. Thus, this classification was considered realistic and practical. In these analyses, similar variables used in the primary analysis were included in the multivariable regression models except for time to epinephrine, and ORs and their 95% CIs were reported. We performed pre-planned subgroup analyses based on bystander witness (witnessed or unwitnessed), first documented rhythm (shockable or non-shockable), and aetiology of cardiac arrest (cardiac or noncardiac) to further examine the association between time to epinephrine and 30-day survival based on a priori hypotheses that there could be major differences among these subgroups. For instance, time from onset of OHCA to epinephrine use could vary between witnessed and unwitnessed groups even if the two groups had exactly the same time interval from call to epinephrine use. The paediatric life support algorithms also vary between witnessed and unwitnessed groups because the aetiology of cardiac arrest could differ depending on bystander witness status. 5, 6 In addition, the effectiveness of epinephrine might vary depending on the pathophysiology or aetiology of cardiac arrest. Moreover, the association between time to epinephrine and outcomes could differ according to initial cardiac rhythm, as previous adult OHCA studies indicated. [28] [29] [30] [31] For each subgroup, the association of time to epinephrine with 30-day survival was estimated in a logistic regression model including the same set of variables used in the regression models for the overall cohort, and ORs and their 95% CIs were reported. Statistical analyses were conducted with JMP Pro 11.2.0 software (SAS Institute Inc., Cary, NC, USA). All hypothesis tests were two-sided with a significance level of 0.05.
Results
We identified 225 paediatric OHCA patients aged > _1 and <18 years during the study period ( Figure 1 ). Of these, 23 (10.2%) survived 30 days after OHCA. The median time from emergency call to first epinephrine administration was 26 min [IQR, 20-32; range, 9-128; mean (SD), 28.7 (15.5) min] in the overall cohort ( Table 1) . Longer time to epinephrine was associated with decreased chance of 30-day survival: 50.0, 41.2, 13.0, 11.6, 3.9, and 3.1%, respectively, when time to epinephrine was categorized into < _10, 11-15, 16-20, 21-25, 26-30 , or >30 min (P for trend <0.0001) (Figure 2) . Table 2 shows the association between time to epinephrine and primary and secondary outcomes. Longer time to epinephrine was associated with decreased chance of 30-day survival in univariable analysis when time to epinephrine was treated as a linear and continuous variable (OR 0.87, 95% CI 0.80-0.93, P < 0.0001). This association remained significant in multivariable analysis, after adjusting for potential confounders (adjusted OR 0.90, 95% CI 0.82-0.96, P = 0.0011). Similar associations observed in 30-day survival were observed in prehospital ROSC (P = 0.0032) and neurologically favourable survival, including different definitions of favourable neurological outcomes [i.e. CPC 1 to 2 (P = 0.0014) or CPC1 (P = 0.0218)]. 
Table 2
Association between time to epinephrine as a linear and continuous variable and each outcome of paediatric out-of-hospital cardiac arrest Table 4 presents the association between time to epinephrine (as a linear and continuous variable) and 30-day survival for various subgroups of patients. Longer time to epinephrine was significantly associated with decreased chance of 30-day survival in the witnessed (P = 0.0035), shockable (P = 0.0004), or cardiac aetiology (P = 0.0013) subgroup. In the other subgroups, although similar trends were observed, there were no statistically significant differences in multivariable analyses.
Discussion
In this nation-wide population-based study of paediatric OHCA from 2005 to 2012, delayed administration of epinephrine was associated with decreased chance of 30-day survival and neurologically favourable survival, as well as prehospital ROSC, among children with OHCA who received prehospital epinephrine. These associations remained after adjusting for potentially confounding patient, event, and EMS characteristics. Although the observational study design precludes ascertainment of causality, the strong association with outcomes suggests that delayed administration of epinephrine may be disadvantageous in paediatric OHCA. To our knowledge, this is the first study to have examined the association between time to epinephrine and outcomes in paediatric OHCA.
No RCTs have directly examined the effectiveness of epinephrine administration during CPR in paediatric cardiac arrest. Only one adult RCT examined that and found a positive effect of epinephrine administration on ROSC and short-term survival, but it was underpowered to detect any differences in long-term outcomes. 32 On the other hand, several large observational studies in adult OHCA have presented conflicting results. 1, 2, 28, 29 These conflicting studies have made clinical decision-making difficult and complex. Current international CPR guidelines recommend administration of epinephrine as the first-line pharmacological intervention in paediatric cardiac arrest, 5, 6 based on the rationale that the strong alpha-adrenergic effects of epinephrine can increase coronary perfusion through increased aortic diastolic pressure and help to maintain cerebral perfusion. 7, 8 In addition, considering that ROSC is a necessary first step to a long-term favourable outcome, epinephrine administration may be beneficial because the association between epinephrine administration and a higher chance of ROSC is a consistent finding across previous studies. 1, 2, 28, 29, 32 Our study showed that delayed administration of epinephrine was associated with decreased prehospital ROSC. In addition, in an examination focusing on only patients who achieved Figure S1 ). It is uncertain whether prolonged time to epinephrine itself affected decreased prehospital ROSC and 30-day survival, or whether time to ROSC did. Although time to epinephrine might be only a surrogate marker of how successfully resuscitation processes was performed, our findings imply that there may be room to improve outcomes after paediatric OHCA by shortening time from emergency call to first epinephrine administration. According to the subgroup analyses, seeking to shorten time to epinephrine may be required, especially in the witnessed, shockable, or cardiac OHCA.
In our study, we found that delayed administration of epinephrine was associated with a decreased chance of favourable outcomes when epinephrine was given during paediatric OHCA, although it was impossible to answer the question whether or not epinephrine should be given during paediatric OHCA. Although there may be some differences between paediatric and adult cardiac arrest or between out-of-hospital and in-hospital cardiac arrest in terms of epidemiology, aetiology, and treatment, our findings in paediatric OHCA population were consistent with those previously reported for adult and paediatric in-hospital non-shockable cardiac arrest. 15, 30 Several limitations should be considered when interpreting our study.
First, despite our attempt to control for potential confounders through multivariable regression modelling, the possibility of unmeasured confounders remains due to the observational study design. The possibility that time to epinephrine is a surrogate marker of other resuscitation processes (including time to defibrillation, time to ROSC, or achievement of ROSC) and not the causal mediator also remains. Although we should also consider the timing of defibrillation because the effect of early epinephrine may vary depending on it, 31 we could not obtain data on it from the All-Japan Utstein Registry. Further study prospectively collecting data on the timing of defibrillation in shockable paediatric OHCA is necessary. In addition, as the overall sample size was small in this study, an adequately powered further study is needed to more precisely determine whether delayed administration of epinephrine is associated with poor outcomes in paediatric OHCA.
Second, the patients who were excluded based on missing or unknown data might decrease the generalizability of our findings. The generalizability of our findings to infants is uncertain because our analysis did not include infants. The generalizability to patients < 8 years is also uncertain. This study included too few patients < 8 years because most municipalities in Japan restrict administration of epinephrine to patients > _ 8 years. In addition, it is unclear whether our findings are applicable to other countries. Different CPR protocols or training systems might lead to different results. In Japan, only 2.5% of paediatric OHCA patients received prehospital epinephrine administration. One reason for this is that epinephrine administration is restricted to patients > _ 8 years, and the other reason is that advanced life support procedures (e.g. epinephrine administration and advanced airway management) can be performed only by specially trained ELST. These restrictions could make our study population different from the typical paediatric OHCA population, 3,4 which could limit its generalizability. In addition, although epinephrine can be administered by EMS personnel only via intravenous line in Japan, different routes of administration (e.g. intraosseous or intratracheal) might result in different results. Third, our study was based on slightly old data (from 2005 to 2012), and there have been several changes in CPR guidelines during and after the study period. Thus, our findings might not necessarily reflect current CPR practices.
Fourth, our study may have included many traumatic OHCA patients in the subgroup of external causes, although it was difficult to distinguish traumatic OHCA from other external causes (e.g. asphyxia or drowning). As previous studies indicated, 33, 34 the effectiveness of epinephrine could differ between traumatic and non-traumatic OHCA. Further study differentiating between traumatic and nontraumatic OHCA may be required. Fifth, the All-Japan Utstein Registry is not specifically designed to answer the current clinical question. As the time variables were recorded in whole minutes, the actual time might have been slightly misclassified. In addition, there is a possibility that the time variables were recorded incorrectly in some cases. These potential misclassifications are unlikely differentiated and could potentially obscure relationships derived from the analytical models.
Sixth, the All-Japan Utstein Registry did not include data on inhospital or post-resuscitation care, although they could significantly affect the outcomes.
Seventh, we could obtain data on outcomes at 30 days after OHCA, not at hospital discharge. In addition, the correlation between CPC and PCPC is unclear, although we used CPC to assess paediatric neurological status. Furthermore, there could be interrater bias in scoring the CPC, although outcome assessors were unaware of the hypotheses of our study. Further study prospectively collecting data on longer-term outcomes using PCPC would be required.
Finally, our study was not designed to evaluate whether epinephrine should be administered in paediatric OHCA. Considering that most patients with paediatric OHCA did not receive prehospital epinephrine administration, further study is needed to determine whether epinephrine should be used, especially what sort of timing it should be used in comparison with no administration of epinephrine.
Conclusions
The results of this nation-wide population-based study of paediatric OHCA from 2005 to 2012 indicated that among children with OHCA who received prehospital epinephrine, delayed administration of epinephrine was associated with decreased chance of 30-day survival and neurologically favourable survival, as well as prehospital ROSC.
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